Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Resistance to beta-lactams--the permutations.

S G B Amyes1

  • 1Medical Microbiology, University of Edinburgh Medical School, Teviot Place, Edinburgh, EH8 9AG, UK.

Journal of Chemotherapy (Florence, Italy)
|March 5, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A potential key role for alpha-haemolysin of <i>Staphylococcus aureus</i> in mediating chondrocyte death in septic arthritis.

Bone & joint research·2018
Same author

Rapid in situ chondrocyte death induced by Staphylococcus aureus toxins in a bovine cartilage explant model of septic arthritis.

Osteoarthritis and cartilage·2013
Same author

Molecular characterisation and diversity in Enterobacter cloacae from Edinburgh and Egypt carrying bla(CTX-M-14) and bla(VIM-4) β-lactamase genes.

International journal of antimicrobial agents·2013
Same author

High frequency of carbapenem-resistant Acinetobacter baumannii in patients with diabetes mellitus in Saudi Arabia.

Journal of medical microbiology·2013
Same author

Diversity in Acinetobacter baumannii isolates from paediatric cancer patients in Egypt.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2013
Same author

Insertion sequence disruption of adeR and ciprofloxacin resistance caused by efflux pumps and gyrA and parC mutations in Acinetobacter baumannii.

International journal of antimicrobial agents·2012
Same journal

Eravacycline in sepsis complicated by <i>Clostridioides difficile</i> infection: a brief case series.

Journal of chemotherapy (Florence, Italy)·2026
Same journal

Apatinib combined with capecitabine plus temozolomide versus sunitinib in advanced gastroenteropancreatic neuroendocrine tumours: a propensity score-matched real-world study.

Journal of chemotherapy (Florence, Italy)·2026
Same journal

Pharmacokinetic/pharmacodynamic optimization of antimicrobial therapy in neutropenic sepsis: a comprehensive review.

Journal of chemotherapy (Florence, Italy)·2026
Same journal

Cefiderocol for <i>Stenotrophomonas maltophilia</i> infections: real-world evidence from a multicenter study and a comprehensive literature review.

Journal of chemotherapy (Florence, Italy)·2026
Same journal

Cefiderocol susceptibility in carbapenem-resistant <i>Acinetobacter baumannii</i>, <i>Pseudomonas aeruginosa</i>, and <i>Stenotrophomonas maltophilia</i> isolates: concordance of disk diffusion with the reference method and comparative analysis of CLSI-EUCAST criteria.

Journal of chemotherapy (Florence, Italy)·2026
Same journal

High-dose continuous infusion of piperacillin/tazobactam via elastomeric pump in a pediatric patient with Kartagener syndrome: pharmacokinetic target attainment and clinical outcome.

Journal of chemotherapy (Florence, Italy)·2026
See all related articles

New penem antibiotics show promise against resistant bacteria. Faropenem, a novel synthetic beta-lactam, offers broad-spectrum activity and stability against beta-lactamase enzymes, addressing key resistance mechanisms in community-acquired infections.

Area of Science:

  • Microbiology
  • Pharmacology
  • Infectious Diseases

Background:

  • Beta-lactam antibiotics (penicillins, cephalosporins) are primary treatments for community-acquired infections.
  • Emerging microbial resistance to beta-lactams threatens treatment efficacy.
  • Key resistance mechanisms include beta-lactamase production, altered penicillin-binding proteins (PBPs), reduced outer membrane permeability, and active efflux.

Purpose of the Study:

  • To evaluate novel beta-lactam antibiotics designed to overcome existing resistance mechanisms.
  • To assess the potential of the penem class, specifically faropenem, against common community-acquired pathogens.
  • To explore new therapeutic options for infections caused by resistant bacteria.

Main Methods:

  • Review of the properties of synthetic beta-lactam classes, focusing on penems.

Related Experiment Videos

  • Analysis of faropenem's spectrum of activity and stability against beta-lactamase hydrolysis.
  • Comparison of penems with traditional penicillins and cephalosporins in addressing resistance.

    • Main Results:

    • Penems represent a unique synthetic beta-lactam class combining penicillin and cephalosporin properties.
    • Penems demonstrate inherent stability against hydrolysis by beta-lactamase enzymes.
    • Faropenem exhibits broad-spectrum activity and is designed to counteract major bacterial resistance mechanisms.

    Conclusions:

    • New beta-lactams must effectively address multiple resistance mechanisms for continued clinical utility.
    • The penem class, exemplified by faropenem, shows significant promise in combating resistant bacteria.
    • Faropenem offers a potential new therapeutic strategy for community-acquired infections, including those with beta-lactam resistance.